glp-1 mash Resmetirom and agonists for MASH: complementary rather than exclusive Comparative Analysis of Resmetirom vs.
Description
placebo cohorts (20)

and 2) a trial-product estimand which includes data collected from all randomized participants prior to premature trial-product discontinuation or initiation of rescue medication ( SIDEBAR 2 )

A., Skene, R

GLP-1 receptor agonists improve insulin sensitivity and promote weight loss in addition to anti-inflammatory properties independent of weight loss, Tah said
